Retatrutide is a triple receptor agonist targeting the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR), with FDA approval for the indication of obesity.Retatrutide may be used in studies of obesity, type 2 diabetes, and non-alcoholic steatohepatitis.
Molecular Weight:
4732.09
Purity:
98.31%
CAS Number:
[2381089-83-2]
Formula:
C221H342N46O68
Target:
Glucagon Receptor
T76279
T76279
* VAT and and shipping costs not included. Errors and price changes excepted
